Amgen
AMGN
#81
Rank
$135.35 B
Marketcap
🇺🇸 USA
Country
$231.10
Share price
0.17%
Change (1 day)
19.80%
Change (1 year)
Categories
The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
Market capitalization of Amgen (AMGN)
Market cap: $135.35 B
As of October 2020 Amgen has a market cap of $135.35 B. This makes Amgen the world's 81th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Market cap history of Amgen from 2001 to 2020
| Year | Market cap | Change |
|---|---|---|
| 2020 | $137.64 B | -3.45% |
| 2019 | $142.56 B | 16.32% |
| 2018 | $122.56 B | -2.91% |
| 2017 | $126.23 B | 16.06% |
| 2016 | $108.76 B | -11.13% |
| 2015 | $122.39 B | 1.05% |
| 2014 | $121.12 B | 40.7% |
| 2013 | $86.08 B | 32.05% |
| 2012 | $65.19 B | 15.83% |
| 2011 | $56.28 B | 10% |
| 2010 | $51.16 B | -9.1% |
| 2009 | $56.28 B | -6.91% |
| 2008 | $60.46 B | 19.78% |
| 2007 | $50.48 B | -36.62% |
| 2006 | $79.64 B | -17.48% |
| 2005 | $96.52 B | 19.42% |
| 2004 | $80.82 B | 1.9% |
| 2003 | $79.31 B | 27.29% |
| 2002 | $62.31 B | 5.57% |
| 2001 | $59.02 B |